The National Academies Institute of Medicine holds a meeting on the safety of FDA approved drugs. The Food and Drug Administration had asked the Institute of Medicine to assess the current system for evaluating the safety of drugs once they reached the market. They talked about recent recalls of approved medication, the approval process, and allegations that approvals were being streamlined to benefit business concerns.